222 related articles for article (PubMed ID: 33322148)
1. Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma.
Lucarelli G; Ferro M; Loizzo D; Bianchi C; Terracciano D; Cantiello F; Bell LN; Battaglia S; Porta C; Gernone A; Perego RA; Maiorano E; Cobelli O; Castellano G; Vincenti L; Ditonno P; Battaglia M
Metabolites; 2020 Dec; 10(12):. PubMed ID: 33322148
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
3. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
[TBL] [Abstract][Full Text] [Related]
5. Y-box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma.
Jeffords E; Freeman S; Cole B; Root K; Chekouo T; Melvin RG; Bemis L; Simmons GE
Oncol Lett; 2020 Nov; 20(5):165. PubMed ID: 32952654
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
[TBL] [Abstract][Full Text] [Related]
8. MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome.
Lucarelli G; Rutigliano M; Loizzo D; di Meo NA; Lasorsa F; Mastropasqua M; Maiorano E; Bizzoca C; Vincenti L; Battaglia M; Ditonno P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430448
[TBL] [Abstract][Full Text] [Related]
9. The Hypoxic Microenvironment Induces Stearoyl-CoA Desaturase-1 Overexpression and Lipidomic Profile Changes in Clear Cell Renal Cell Carcinoma.
Melana JP; Mignolli F; Stoyanoff T; Aguirre MV; Balboa MA; Balsinde J; Rodríguez JP
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34199164
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.
Tan SK; Hougen HY; Merchan JR; Gonzalgo ML; Welford SM
Nat Rev Urol; 2023 Jan; 20(1):48-60. PubMed ID: 36192502
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer.
Huang Q; Wang Q; Li D; Wei X; Jia Y; Zhang Z; Ai B; Cao X; Guo T; Liao Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):129. PubMed ID: 30876460
[TBL] [Abstract][Full Text] [Related]
12. Potential Links between YB-1 and Fatty Acid Synthesis in Clear Cell Renal Carcinoma.
McCauley C; Anang V; Cole B; Simmons GE
Med Res Arch; 2020 Oct; 8(10):. PubMed ID: 33778158
[TBL] [Abstract][Full Text] [Related]
13. Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case-control study within the ATBC cohort.
Barupal DK; Ramos ML; Florio AA; Wheeler WA; Weinstein SJ; Albanes D; Fiehn O; Graubard BI; Petrick JL; McGlynn KA
Int J Cancer; 2024 Feb; 154(3):454-464. PubMed ID: 37694774
[TBL] [Abstract][Full Text] [Related]
14. ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.
Klasson TD; LaGory EL; Zhao H; Huynh SK; Papandreou I; Moon EJ; Giaccia AJ
Cancer Metab; 2022 Oct; 10(1):14. PubMed ID: 36192773
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
16. Stearoyl-CoA desaturase 1 deficiency reduces lipid accumulation in the heart by activating lipolysis independently of peroxisome proliferator-activated receptor α.
Bednarski T; Olichwier A; Opasinska A; Pyrkowska A; Gan AM; Ntambi JM; Dobrzyn P
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):2029-2037. PubMed ID: 27751891
[TBL] [Abstract][Full Text] [Related]
17. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.
Roongta UV; Pabalan JG; Wang X; Ryseck RP; Fargnoli J; Henley BJ; Yang WP; Zhu J; Madireddi MT; Lawrence RM; Wong TW; Rupnow BA
Mol Cancer Res; 2011 Nov; 9(11):1551-61. PubMed ID: 21954435
[TBL] [Abstract][Full Text] [Related]
18. Integration of clinical and transcriptomics reveals programming of the lipid metabolism in gastric cancer.
Li Y; Zhao J; Chen R; Chen S; Xu Y; Cai W
BMC Cancer; 2022 Sep; 22(1):955. PubMed ID: 36064336
[TBL] [Abstract][Full Text] [Related]
19. Expression and regulation of delta5-desaturase, delta6-desaturase, stearoyl-coenzyme A (CoA) desaturase 1, and stearoyl-CoA desaturase 2 in rat testis.
Saether T; Tran TN; Rootwelt H; Christophersen BO; Haugen TB
Biol Reprod; 2003 Jul; 69(1):117-24. PubMed ID: 12606372
[TBL] [Abstract][Full Text] [Related]
20. Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer.
Tracz-Gaszewska Z; Dobrzyn P
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31284458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
